AI And Earnings Expansion Support Oracle's Valuation
Oracle, driven by AI and cloud, projects a 15% stock price CAGR potential over five years, and a fair valuation amid a ...
In the Court of King Trump
The second Trump White House is starting out with a remarkable degree of conflict among different individuals, constituencies ...
University of Arkansas2d
Oracle Ceo Larry Ellison Announces $7 Million Gift-In-Kind To UA Walton College’s It Research Center
FAYETTEVILLE, Ark. - Larry Ellison, Chairman and CEO of Oracle Corporation, the world's leading supplier of software for information management, announced that Oracle has donated software and ...
Anti-Vax Conspiracy Theorists Freak Out Over Trump’s $500 Billion AI Plan
The Stargate Initiative, spearheaded by several tech giants, has raised alarm in the most paranoid parts of the MAGA movement ...
Certara Inc. (CERT): Accelerating Drug Development with AI Amid Leerink’s Target Price Boost to $13
We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...
GEN2d
StockWatch: Up-to-$500B AI Venture Sparks Investor Interest, and Questions
Stargate CEOs cite project’s promise of enabling cancer vaccines, though Musk joins critics in questioning partners’ ...
Relay Therapeutics Inc (RLAY): AI-Driven Cancer Treatments Backed by Barclays’ $17 Price Target
Relay Therapeutics Inc. (NASDAQ:RLAY) is a leading clinical-stage precision medicines firm focused on cancer treatments. The ...
S&P 500 Gains and Losses Today: Electronic Arts Drops as Game Maker Cuts Forecast
The S&P 500 gained 0.5% on Thursday, Jan. 23, reaching a record close as President Donald Trump pressed for lower oil prices ...
Why I Don’t Believe Larry Ellison’s Moderna Stock Hype
MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...